Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting

Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-[4-(p-maleimidophenyl)butyryl]phosphatidylethanolamine (MPB-PE). A highly efficient reaction between the sulfhydryl group on each Fab' fra...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 257; no. 1; pp. 286 - 288
Main Authors MARTIN, F. J, PAPAHADHOPOULOS, D
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Biochemistry and Molecular Biology 01.01.1982
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-[4-(p-maleimidophenyl)butyryl]phosphatidylethanolamine (MPB-PE). A highly efficient reaction between the sulfhydryl group on each Fab' fragment and the maleimide moiety of MPB-PE molecules incorporated at a low concentration in vesicle bilayers led to the formation of a highly stable Fab'-vesicle linkage. Coupling ratios in excess of 250 micrograms of Fab'/mumol of vesicle phospholipid were reproduciably obtained without vesicle aggregation. Bound Fab' fragments did not elute from vesicles in serum or in the presence of reducing agents (dithiothreitol or mercaptoethanol). Vesicles bearing Fab' fragments raised against specific human erythrocyte surface determinants bound selectively to human erythrocytes under physiological conditions (isotonic medium containing 50% human serum, pH 7.4) with minimal leakage of vesicle contents. Advantages of the present coupling method are discussed in relationship to our effects to optimize the properties of liposomes as a carrier system.
AbstractList Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-(4-(P-maleimidophenyl)butyryl)phosphatidylethanolamine (MPB-PE). A highly efficient reaction between the sulfhydryl group on each Fab' fragment and the maleimide moiety of MPB-PE molecules incorporated at a low concentration in vesicle bilayers led to the formation of a highly stable Fab'-vesicle linkage. Vesicles bearing Fab' fragments raised against specific human erythrocyte surface determinants bound selectively to human erythrocytes under physiological conditions (isotonic medium containing 50% human serum, pH 7.4) with minimal leakage of vesicle contents.
Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-[4-(p-maleimidophenyl)butyryl]phosphatidylethanolamine (MPB-PE). A highly efficient reaction between the sulfhydryl group on each Fab' fragment and the maleimide moiety of MPB-PE molecules incorporated at a low concentration in vesicle bilayers led to the formation of a highly stable Fab'-vesicle linkage. Coupling ratios in excess of 250 micrograms of Fab'/mumol of vesicle phospholipid were reproduciably obtained without vesicle aggregation. Bound Fab' fragments did not elute from vesicles in serum or in the presence of reducing agents (dithiothreitol or mercaptoethanol). Vesicles bearing Fab' fragments raised against specific human erythrocyte surface determinants bound selectively to human erythrocytes under physiological conditions (isotonic medium containing 50% human serum, pH 7.4) with minimal leakage of vesicle contents. Advantages of the present coupling method are discussed in relationship to our effects to optimize the properties of liposomes as a carrier system.
Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative N-[4-(p-maleimidophenyl)butyryl]phosphatidylethanolamine (MPB-PE). A highly efficient reaction between the sulfhydryl group on each Fab' fragment and the maleimide moiety of MPB-PE molecules incorporated at a low concentration in vesicle bilayers led to the formation of a highly stable Fab'-vesicle linkage. Coupling ratios in excess of 250 micrograms of Fab'/mumol of vesicle phospholipid were reproduciably obtained without vesicle aggregation. Bound Fab' fragments did not elute from vesicles in serum or in the presence of reducing agents (dithiothreitol or mercaptoethanol). Vesicles bearing Fab' fragments raised against specific human erythrocyte surface determinants bound selectively to human erythrocytes under physiological conditions (isotonic medium containing 50% human serum, pH 7.4) with minimal leakage of vesicle contents. Advantages of the present coupling method are discussed in relationship to our effects to optimize the properties of liposomes as a carrier system.
Author F J Martin
D Papahadjopoulos
Author_xml – sequence: 1
  givenname: F. J
  surname: MARTIN
  fullname: MARTIN, F. J
  organization: Univ. California, cancer res. inst
– sequence: 2
  givenname: D
  surname: PAPAHADHOPOULOS
  fullname: PAPAHADHOPOULOS, D
  organization: Univ. California, cancer res. inst
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9397195$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7053372$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9r3DAQxUVJSTdpP0JAhVLag1ONZEnWMYT-CQR6aAu9CVs79qpYlivZW_rtq80ue-1cBmZ-byTeuyIXU5yQkBtgt8BAffjGGIfKcNm8A_NeNUKaSj0jG2CNqISEnxdkc0ZekKucf7FStYFLcqmZFELzDUkPKeEeU_bdiNTFdR79NNDYUx_COsVhjN1aRrRP7RBwWjJdIp0T9jEF3NI9Zu9GzLf0biqSOcV9mQZcdnFLC0NHP8ccA9KlTQMu5fhL8rxvx4yvTv2a_Pj08fv9l-rx6-eH-7vHytVCL5WCHnkvQXRMCdc3HNAZaLQUWnfIVN9z5tgWhEZuwDSt1rVzamtcozlDLq7J2-Pd8qnfK-bFBp8djmM7YVyz1cIA47X6LwiyFpzrAyiPoEsx5-KBnZMPbfprgdlDKPYpFHtw3IKxT6HYg-7m9MDaFdPOqlMKZf_mtG-za8di9eR8PmNGGA1GFuz1Edv5YffHJ7Sdj26HwXKpLVjeKPEP_MijGQ
CODEN JBCHA3
CitedBy_id crossref_primary_10_1002__SICI_1521_4141_199907_29_07_2297__AID_IMMU2297_3_0_CO_2_5
crossref_primary_10_1016_0005_2736_88_90545_7
crossref_primary_10_1016_j_chemphyslip_2015_03_004
crossref_primary_10_1016_0009_3084_86_90080_0
crossref_primary_10_1016_0006_291X_83_91214_7
crossref_primary_10_1016_S0169_409X_96_00461_9
crossref_primary_10_1007_BF02316446
crossref_primary_10_1208_s12248_012_9330_0
crossref_primary_10_3109_03639049309069345
crossref_primary_10_1111_j_1751_1097_1988_tb02731_x
crossref_primary_10_1016_0022_1759_90_90394_B
crossref_primary_10_1016_0005_2736_83_90332_2
crossref_primary_10_1016_0005_2736_89_90492_6
crossref_primary_10_1016_0005_2736_93_90071_7
crossref_primary_10_1016_0005_2736_86_90147_1
crossref_primary_10_1016_0009_3084_86_90078_2
crossref_primary_10_1016_0022_1759_86_90075_X
crossref_primary_10_1016_0167_4889_88_90184_X
crossref_primary_10_1080_00397919208019100
crossref_primary_10_1111_j_1749_6632_1985_tb18412_x
crossref_primary_10_1016_S0005_2728_88_80099_9
crossref_primary_10_1016_0005_2736_85_90528_0
crossref_primary_10_1016_j_jconrel_2016_09_006
crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2022039241
crossref_primary_10_1073_pnas_93_24_14164
crossref_primary_10_1016_0005_2736_94_00300_E
crossref_primary_10_3109_08982109909044498
crossref_primary_10_1002_bit_260360510
crossref_primary_10_1111_j_1751_1097_1988_tb02730_x
crossref_primary_10_2217_nnm_12_128
crossref_primary_10_1155_2016_1625149
crossref_primary_10_1155_2015_198175
crossref_primary_10_1021_js9603515
crossref_primary_10_1081_DDC_120006433
crossref_primary_10_1016_0168_3659_91_90038_F
crossref_primary_10_3390_nano10091674
crossref_primary_10_1097_00004424_200004000_00003
crossref_primary_10_3109_08982109409037064
crossref_primary_10_1007_s13233_018_6021_4
crossref_primary_10_1016_0005_2736_94_90219_4
crossref_primary_10_1016_0022_1759_83_90125_4
crossref_primary_10_1016_S0264_410X_99_00198_X
crossref_primary_10_1016_0167_4889_86_90212_0
crossref_primary_10_1111_j_1749_6632_1990_tb18187_x
crossref_primary_10_1016_S0169_409X_97_00134_8
crossref_primary_10_1016_0169_409X_94_90016_7
crossref_primary_10_1016_S0005_2728_88_80107_5
crossref_primary_10_1016_0163_7258_85_90058_0
crossref_primary_10_1016_0167_4889_88_90192_9
crossref_primary_10_1111_j_1749_6632_1991_tb27256_x
crossref_primary_10_3109_08982109809039930
crossref_primary_10_1016_0022_1759_93_90257_8
crossref_primary_10_1016_0166_0934_88_90156_5
crossref_primary_10_1006_abio_2001_5443
crossref_primary_10_1039_D1NA00696G
crossref_primary_10_1007_BF00731021
crossref_primary_10_1016_0161_5890_91_90131_3
crossref_primary_10_1016_j_ejpb_2020_05_019
crossref_primary_10_1007_BF02446525
crossref_primary_10_1002_med_2610060203
crossref_primary_10_1248_cpb_36_1086
crossref_primary_10_1002_jps_20098
crossref_primary_10_1158_1078_0432_CCR_03_0041
crossref_primary_10_1016_S0005_2736_99_00074_7
crossref_primary_10_1017_S1431927609090424
crossref_primary_10_1016_0005_2736_88_90016_8
crossref_primary_10_1002_jps_2600791107
crossref_primary_10_1016_S0735_1097_98_00607_X
crossref_primary_10_1002_j_1552_4604_1989_tb03403_x
crossref_primary_10_1016_S0022_1759_97_00041_0
crossref_primary_10_1016_0003_2697_83_90744_3
crossref_primary_10_1002_marc_1989_030101108
crossref_primary_10_1007_BF02074854
crossref_primary_10_1111_j_2042_7158_1993_tb03678_x
crossref_primary_10_1016_0165_2478_91_90040_H
crossref_primary_10_1016_j_ejpb_2014_11_016
crossref_primary_10_1016_0165_2478_94_00251_L
crossref_primary_10_1007_BF02703901
crossref_primary_10_1016_S0161_5890_97_00090_4
crossref_primary_10_1111_j_1749_6632_1985_tb18414_x
crossref_primary_10_1021_la981253x
crossref_primary_10_1016_0005_2736_95_00138_S
crossref_primary_10_1007_BF03218456
crossref_primary_10_1016_0168_3659_94_90162_7
crossref_primary_10_1016_0024_3205_86_90010_X
crossref_primary_10_1002_smll_201703045
crossref_primary_10_1021_acs_chemrev_4c00009
crossref_primary_10_17352_2455_8591_000003
crossref_primary_10_1016_0378_5173_95_04325_X
crossref_primary_10_1016_0022_1759_84_90119_4
crossref_primary_10_1016_S0005_2736_01_00411_4
crossref_primary_10_1016_S0040_4039_01_01441_1
crossref_primary_10_1016_0006_2952_88_90584_9
crossref_primary_10_1211_0022357055830
crossref_primary_10_1038_sj_cgt_7700311
crossref_primary_10_1016_0014_5793_94_01350_A
crossref_primary_10_1002_jbm_a_34189
crossref_primary_10_1016_j_jconrel_2005_08_021
crossref_primary_10_3109_08982109509012668
crossref_primary_10_1016_0005_2736_89_90277_0
crossref_primary_10_1016_0005_2736_90_90267_R
crossref_primary_10_1016_0163_7827_92_90001_Y
crossref_primary_10_1021_la990817
crossref_primary_10_1080_1061186X_2019_1648479
crossref_primary_10_1016_j_biomaterials_2011_11_012
crossref_primary_10_1016_0014_5793_88_80854_8
crossref_primary_10_1016_0005_2736_88_90346_X
crossref_primary_10_1016_S0169_409X_99_00043_5
crossref_primary_10_1111_j_1749_6632_1985_tb18417_x
crossref_primary_10_1021_acs_nanolett_1c01666
crossref_primary_10_1602_neurorx_2_1_99
crossref_primary_10_1016_0022_1759_93_90146_X
crossref_primary_10_1007_s11095_018_2365_x
crossref_primary_10_3109_08982109309150737
crossref_primary_10_1089_cdd_1984_1_251
crossref_primary_10_3109_08982109509012677
crossref_primary_10_1016_0005_2736_94_90021_3
crossref_primary_10_1016_S0021_9258_17_44020_8
crossref_primary_10_1016_0040_4039_96_01685_1
crossref_primary_10_1016_S0163_7827_00_00004_7
crossref_primary_10_1016_0014_5793_93_80509_S
crossref_primary_10_1007_BF01786880
crossref_primary_10_3109_08982109609037210
crossref_primary_10_1016_0167_4889_87_90047_4
crossref_primary_10_1016_0005_2736_87_90267_7
crossref_primary_10_1016_0022_1759_90_90239_R
crossref_primary_10_3109_08982109509012671
crossref_primary_10_1016_S0003_4509_05_82256_4
crossref_primary_10_3109_08982109509012673
crossref_primary_10_1016_S0163_7827_03_00032_8
crossref_primary_10_1021_js9604467
crossref_primary_10_1111_j_1749_6632_1985_tb18420_x
crossref_primary_10_3109_08982109509012686
crossref_primary_10_1016_0042_6822_84_90344_1
crossref_primary_10_1016_0014_4827_87_90420_4
crossref_primary_10_1016_j_chemphyslip_2004_10_005
crossref_primary_10_3109_08982108909035996
crossref_primary_10_1021_acsabm_3c00842
crossref_primary_10_3109_08982101003754401
crossref_primary_10_1016_0005_2736_86_90068_4
crossref_primary_10_1016_0003_2697_85_90507_X
crossref_primary_10_1016_0005_2736_84_90512_1
crossref_primary_10_1016_0005_2736_84_90145_7
crossref_primary_10_1016_j_ijpharm_2013_06_006
crossref_primary_10_1016_0005_2736_85_90430_4
crossref_primary_10_1016_0005_2736_87_90114_3
crossref_primary_10_1016_j_biomaterials_2004_07_047
crossref_primary_10_1021_la0005964
crossref_primary_10_1016_0014_5793_93_80861_N
crossref_primary_10_1016_j_jconrel_2014_04_047
crossref_primary_10_1002_mc_2940040612
crossref_primary_10_1039_B606930D
crossref_primary_10_1016_0006_2944_83_90044_3
crossref_primary_10_1016_0014_5793_96_01055_1
crossref_primary_10_1016_S0005_2736_99_00137_6
crossref_primary_10_3109_08982109809039928
crossref_primary_10_1016_0005_2736_89_90037_0
crossref_primary_10_1016_0169_409X_89_90027_6
crossref_primary_10_1016_j_jconrel_2018_03_002
crossref_primary_10_1016_S0378_4347_00_81101_9
crossref_primary_10_1126_science_7871422
crossref_primary_10_1016_0304_4165_85_90187_4
crossref_primary_10_1016_S0021_9258_17_42772_4
crossref_primary_10_1016_S0021_9258_19_49621_X
crossref_primary_10_1016_0022_1759_95_00284_7
crossref_primary_10_1111_j_1749_6632_1987_tb45792_x
crossref_primary_10_1111_jphp_12513
crossref_primary_10_1007_BF02975142
crossref_primary_10_1155_2019_9293560
crossref_primary_10_1038_sj_bjc_6690588
crossref_primary_10_1016_S0169_409X_96_00402_4
crossref_primary_10_1016_0022_1759_83_90242_9
crossref_primary_10_1016_j_jconrel_2011_01_001
crossref_primary_10_1111_j_1749_6632_1985_tb18411_x
crossref_primary_10_1016_j_nano_2016_06_008
crossref_primary_10_1067_mje_2000_105840
crossref_primary_10_1016_0161_5890_93_90028_A
crossref_primary_10_1016_j_ejpb_2018_09_017
crossref_primary_10_1016_0922_338X_92_80005_4
crossref_primary_10_3109_10837450_2015_1063651
crossref_primary_10_1002_eji_1830210128
crossref_primary_10_1016_S0040_4039_01_00032_6
crossref_primary_10_1080_17425247_2018_1471058
crossref_primary_10_1186_1556_276X_6_620
crossref_primary_10_1039_b822319j
crossref_primary_10_1016_0264_410X_95_00028_Y
crossref_primary_10_1002_chem_200500480
crossref_primary_10_1007_s11745_000_0572_4
crossref_primary_10_1016_j_ejps_2020_105520
crossref_primary_10_1002__SICI_1097_0215_19990301_80_5_723__AID_IJC16_3_0_CO_2_L
crossref_primary_10_1002__SICI_1097_0282_1997_43_1_15__AID_BIP3_3_0_CO_2_3
crossref_primary_10_1016_0005_2736_92_90352_M
crossref_primary_10_1016_0924_4247_95_01076_9
crossref_primary_10_1016_j_addr_2012_09_021
crossref_primary_10_1039_B906701A
crossref_primary_10_1208_pt070232
crossref_primary_10_1016_0163_7258_84_90035_4
crossref_primary_10_1016_S0378_5173_00_00590_1
crossref_primary_10_1039_C3SM51515J
crossref_primary_10_1016_0005_2736_86_90247_6
crossref_primary_10_1016_0005_2736_88_90461_0
crossref_primary_10_1016_S0169_409X_00_00069_7
crossref_primary_10_1002_admi_201901676
crossref_primary_10_1016_0005_2736_95_00085_H
crossref_primary_10_1016_S0022_1759_87_80006_6
crossref_primary_10_1016_j_addr_2012_09_031
crossref_primary_10_1002__SICI_1099_1352_199634_12_9_5_6_335__AID_JMR309_3_0_CO_2_0
crossref_primary_10_1248_bpb_33_1766
crossref_primary_10_1007_s00216_008_1992_1
crossref_primary_10_1016_0005_2736_91_90135_U
crossref_primary_10_1021_bm060192b
crossref_primary_10_1016_0003_2697_89_90335_7
crossref_primary_10_1016_0005_2736_90_90334_K
crossref_primary_10_1016_0005_2736_95_00145_S
Cites_doi 10.1016/S0021-9258(19)70595-X
10.1016/0005-2736(79)90085-3
10.1021/bi00517a043
10.1073/pnas.75.9.4194
10.1093/oxfordjournals.jbchem.a131053
10.1016/0005-2736(81)90532-0
10.1016/0005-2736(80)90558-1
10.1016/S0021-9258(17)32959-9
10.1038/288602a0
10.1042/bj1330529
10.1016/S0021-9258(19)70482-7
10.1126/science.7423203
10.1016/S0006-291X(75)80180-X
ContentType Journal Article
Copyright 1984 INIST-CNRS
Copyright_xml – notice: 1984 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
8FD
C1K
FR3
H94
M7Z
P64
7X8
DOI 10.1016/S0021-9258(19)68359-6
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Biochemistry Abstracts 1
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Technology Research Database
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1083-351X
EndPage 288
ExternalDocumentID 10_1016_S0021_9258_19_68359_6
7053372
9397195
257_1_286
Genre Journal Article
GroupedDBID -
02
08R
186
2WC
3O-
53G
55
5BI
5GY
5RE
5VS
85S
AARDX
AAWZA
AAYJJ
ABFLS
ABOCM
ABPPZ
ABPTK
ABUFD
ABZEH
ACNCT
ADACO
ADBBV
ADBIT
ADCOW
AEILP
AENEX
AFFNX
AFMIJ
AIZTS
ALMA_UNASSIGNED_HOLDINGS
C1A
CJ0
CS3
DIK
DL
DU5
DZ
E3Z
EBS
EJD
ET
F20
F5P
FA8
FRP
GJ
GX1
H13
HH5
IH2
J5H
KM
KQ8
L7B
LI
MVM
MYA
N9A
NHB
O0-
OHM
OHT
OK1
P-O
P0W
P2P
R.V
RHF
RHI
RNS
RPM
SJN
TBC
TN5
UHB
UPT
UQL
VH1
VQA
WH7
WOQ
X
X7M
XFK
XHC
XJT
Y6R
YZZ
ZA5
ZGI
ZY4
---
-DZ
-ET
-~X
.55
.GJ
0SF
18M
29J
34G
39C
4.4
41~
6TJ
79B
8W4
AAXUO
AAYOK
ABDNZ
ABFSI
ABRJW
ABTAH
ACGFO
ACSFO
ACYGS
ADGIM
ADIYS
ADNWM
AFDAS
AI.
AOIJS
BAWUL
BTFSW
E.L
FDB
GROUPED_DOAJ
HYE
IQODW
QZG
ROL
TR2
UKR
W8F
WHG
XSW
YQT
YSK
YWH
YYP
ZE2
~02
~KM
0R~
AAEDW
AAFWJ
AALRI
ADVLN
AEXQZ
AFOSN
AFPKN
AITUG
AKRWK
AMRAJ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
8FD
C1K
FR3
H94
M7Z
P64
7X8
ID FETCH-LOGICAL-c437t-61fe2f513b063cf821ec91875377be06ff20c0d137e29198a774cc6d9c8720e23
ISSN 0021-9258
IngestDate Sat Oct 26 00:25:24 EDT 2024
Thu Oct 24 23:17:43 EDT 2024
Fri Aug 23 01:12:33 EDT 2024
Sat Sep 28 08:25:15 EDT 2024
Fri Nov 25 06:01:48 EST 2022
Tue Jan 05 14:52:10 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c437t-61fe2f513b063cf821ec91875377be06ff20c0d137e29198a774cc6d9c8720e23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/s0021-9258(19)68359-6
PMID 7053372
PQID 15432276
PQPubID 23462
PageCount 3
ParticipantIDs proquest_miscellaneous_73910246
proquest_miscellaneous_15432276
crossref_primary_10_1016_S0021_9258_19_68359_6
pubmed_primary_7053372
pascalfrancis_primary_9397195
highwire_biochem_257_1_286
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 1982-01-01
PublicationDateYYYYMMDD 1982-01-01
PublicationDate_xml – month: 01
  year: 1982
  text: 1982-01-01
  day: 01
PublicationDecade 1980
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 1982
Publisher American Society for Biochemistry and Molecular Biology
Publisher_xml – name: American Society for Biochemistry and Molecular Biology
References Fraley (10.1016/S0021-9258(19)68359-6_bib13) 1980; 255
Olson (10.1016/S0021-9258(19)68359-6_bib4) 1979; 557
Huang (10.1016/S0021-9258(19)68359-6_bib10) 1981; 255
Szoka (10.1016/S0021-9258(19)68359-6_bib3) 1978; 75
Martin (10.1016/S0021-9258(19)68359-6_bib1) 1981; 20
Kitagawa (10.1016/S0021-9258(19)68359-6_bib11) 1976; 79
Gregoriadis (10.1016/S0021-9258(19)68359-6_bib8) 1975; 65
Bolton (10.1016/S0021-9258(19)68359-6_bib5) 1973; 133
Mayhew (10.1016/S0021-9258(19)68359-6_bib14) 1979; 63
Leserman (10.1016/S0021-9258(19)68359-6_bib2) 1980; 288
Szoka (10.1016/S0021-9258(19)68359-6_bib12) 1980; 601
Heath (10.1016/S0021-9258(19)68359-6_bib9) 1980; 210
Heath (10.1016/S0021-9258(19)68359-6_bib6) 1981; 640
Abbott (10.1016/S0021-9258(19)68359-6_bib7) 1976; 251
References_xml – volume: 255
  start-page: 8015
  year: 1981
  ident: 10.1016/S0021-9258(19)68359-6_bib10
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)70595-X
  contributor:
    fullname: Huang
– volume: 63
  start-page: 1923
  year: 1979
  ident: 10.1016/S0021-9258(19)68359-6_bib14
  publication-title: Cancer Treatment Rep.
  contributor:
    fullname: Mayhew
– volume: 557
  start-page: 9
  year: 1979
  ident: 10.1016/S0021-9258(19)68359-6_bib4
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0005-2736(79)90085-3
  contributor:
    fullname: Olson
– volume: 20
  start-page: 4229
  year: 1981
  ident: 10.1016/S0021-9258(19)68359-6_bib1
  publication-title: Biochemistry
  doi: 10.1021/bi00517a043
  contributor:
    fullname: Martin
– volume: 75
  start-page: 4194
  year: 1978
  ident: 10.1016/S0021-9258(19)68359-6_bib3
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.75.9.4194
  contributor:
    fullname: Szoka
– volume: 79
  start-page: 233
  year: 1976
  ident: 10.1016/S0021-9258(19)68359-6_bib11
  publication-title: J. Biochem.
  doi: 10.1093/oxfordjournals.jbchem.a131053
  contributor:
    fullname: Kitagawa
– volume: 640
  start-page: 66
  year: 1981
  ident: 10.1016/S0021-9258(19)68359-6_bib6
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0005-2736(81)90532-0
  contributor:
    fullname: Heath
– volume: 601
  start-page: 559
  year: 1980
  ident: 10.1016/S0021-9258(19)68359-6_bib12
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0005-2736(80)90558-1
  contributor:
    fullname: Szoka
– volume: 251
  start-page: 7176
  year: 1976
  ident: 10.1016/S0021-9258(19)68359-6_bib7
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(17)32959-9
  contributor:
    fullname: Abbott
– volume: 288
  start-page: 602
  year: 1980
  ident: 10.1016/S0021-9258(19)68359-6_bib2
  publication-title: Nature (London)
  doi: 10.1038/288602a0
  contributor:
    fullname: Leserman
– volume: 133
  start-page: 529
  year: 1973
  ident: 10.1016/S0021-9258(19)68359-6_bib5
  publication-title: Biochem. J.
  doi: 10.1042/bj1330529
  contributor:
    fullname: Bolton
– volume: 255
  start-page: 10431
  year: 1980
  ident: 10.1016/S0021-9258(19)68359-6_bib13
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)70482-7
  contributor:
    fullname: Fraley
– volume: 210
  start-page: 539
  year: 1980
  ident: 10.1016/S0021-9258(19)68359-6_bib9
  publication-title: Science
  doi: 10.1126/science.7423203
  contributor:
    fullname: Heath
– volume: 65
  start-page: 537
  year: 1975
  ident: 10.1016/S0021-9258(19)68359-6_bib8
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(75)80180-X
  contributor:
    fullname: Gregoriadis
SSID ssj0000491
Score 1.6120266
Snippet Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative...
Rabbit Fab' antibody fragments were covalently couple to preformed large unilamellar vesicles using a new sulfhydryl-reactive phospholipid derivative...
SourceID proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 286
SubjectTerms Animals
antibodies
Artificial membranes and reconstituted systems
Biological and medical sciences
Erythrocytes - immunology
Fab
Fundamental and applied biological sciences. Psychology
Humans
Immunoglobulin Fab Fragments
Immunoglobulin G
Liposomes
Membrane physicochemistry
Molecular biophysics
N-(4-(p-maleimidophehyl)butyryl)phosphatidylethanolamine
Phosphatidylethanolamines
Rabbits
Sheep
Sulfhydryl Reagents
vesicles
Title Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting
URI http://www.jbc.org/content/257/1/286.abstract
https://www.ncbi.nlm.nih.gov/pubmed/7053372
https://search.proquest.com/docview/15432276
https://search.proquest.com/docview/73910246
Volume 257
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgPMALgo2J7gJ-AARC6WLn6seqrNqgGyBa1DcrcWxg2pKqTR_g13Nsx0krdeLyErWW5Uj-vtjnHJ_zGaEXrCBMCel7VGXMCwNZeGmohJeFKsiKMIIdStcOX1zGZ9Pw_SyadYIKprqkzvvi19a6kv9BFdoAV10l-w_ItoNCA_wGfOEJCMPzrzA-X2gBJnD3dfnTsFrNr5sc5nNd9VFpsQ-TaA7W6TdbylabpAttqIKh-VUuTVJc34QGTXQBWi_MndIm_XD8Y14tqxv5dmLyxd0ud9UxbM2etXJOVnDE3SLXxbudWMGoO4f6BPv096y4qubV6tpm-73rghCEpXQtCOGKAojHqFVhdwsrtdLTGwxqlkknf938S7cu5jau8KUdWytXsZeUxWA1Mm-LgPblRz6ajsd8cjqb3EX3KKw9Osvvw-dOQB4cInuJYjNmV9R10r3oNWFvmpdsmitOQlpn0GZLmFBlbz-53T0xZsrkEXrY4IEHliyP0R1Z7qK9QZnV1c1P_AqbjF9zlLKL7g8dTntosc4l7LiEK4U3uYRbLuG6wi2XcMslPCix4xK2XMLQBzsu4ZZLT9B0dDoZnnnNfRyeCIOk9mKiJFURCXKwa4VKKZGCEe3wJkku_Vgp6gu_IEEiKQOWZOBaCBEXTKQJ9SUN9tFOWZXyKcJxppRKfREFeRTmaZRR8NPDIiMyieKUsh7qu2nncyu7wrt8RMCJa5w4YdzgxOMeOnDgcOC75jkH_nHCgWs9dLwBVzskA2ucsKiHnjv4OEy7PjLLSlmtlhwcDNjxkvj2HkkAyxkNoce-xb0dPNFl7gk9-OPgh-iB_aZ0WukR2qkXK3kMpm6dPzPk_Q1ZRKoW
link.rule.ids 315,783,787,27938,27939
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Irreversible+Coupling+of+Immunoglobulin+Fragments+to+Preformed+Vesicles.+An+Improved+Method+for+Liposome+Targeting&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Martin%2C+F+J&rft.au=Papahadjopoulos%2C+D&rft.date=1982-01-01&rft.issn=0021-9258&rft.volume=257&rft.issue=1&rft.spage=286&rft.epage=288&rft_id=info:doi/10.1016%2FS0021-9258%2819%2968359-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon